Boston Scientific Corporation BSX
Set alert
44.32 USD +2.34 +5.57%
At close · Nov 2
44.29 -0.03 -0.07%
After hours · Nov 2, 7:50 PM ET
41.90 Day range 44.36
39.57 52-week range 105.65
- YTD
- -53.52%
- 1 year
- -56.00%
- Open
- 42.07
- Prev close
- 41.98
- Mkt cap
- 64.23B
- Vol
- 22.71M
- Avg vol
- 19.60M
- EPS
- 2.37
- P/E
- 18.70
- Div yield
- 0.00%
More statistics
- Low
- 41.90
- High
- 44.36
- Forward P/E
- 14.10
- Beta
- 0.58
- Short ratio
- 2.17
- Inst. own
- 94.97%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 3, 2027
- 50-d avg
- 44.79
- 200-d avg
- 56.52
- 1y target
- 50.03
5D chart
Events in this range
- Oct 28, 2026Earnings: 0.73; estimate 0.727; surprise 0.41%
- Oct 29, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 29, 2026Rating: Bernstein · Outperform → Outperform
- Oct 29, 2026Rating: Canaccord Genuity · Buy → Buy
- Oct 29, 2026Downgrade: Jefferies · Buy → Hold
- Oct 30, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Oct 30, 2026Downgrade: TD Cowen · Buy → Hold
Signals (101)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 3:25 PM | 7 hours ago |
| SMA: Bullish | Nov 2, 3:15 PM | 8 hours ago |
| SMA: Bullish | Nov 2, 3:15 PM | 8 hours ago |
| SMA: Bearish | Nov 2, 2:45 PM | 8 hours ago |
| SMA: Bullish | Nov 2, 2:40 PM | 8 hours ago |
| SMA: Bearish | Nov 2, 2:35 PM | 8 hours ago |
| SMA: Bearish | Nov 2, 2:30 PM | 8 hours ago |
| SMA: Bullish | Nov 2, 2:00 PM | 9 hours ago |
| SMA: Bullish | Nov 2, 1:50 PM | 9 hours ago |
| SMA: Bearish | Nov 2, 1:30 PM | 9 hours ago |
| SMA: Bearish | Nov 2, 1:20 PM | 9 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 12:40 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 12:35 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 12:15 PM | 11 hours ago |
| MACD: Sell Signal | Nov 2, 12:10 PM | 11 hours ago |
| RSI: Overbought | Nov 2, 9:50 AM | 13 hours ago |
| SMA: Bullish | Oct 30, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:55 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:25 PM | 3 days ago |
Newest 20 of 101.
Financial health
Altman Z-Score
2.89 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 3
- P/B 1
Valuation
P/E 48.6×
FY 2016 5y median 61.3× FY 2025
P/S 7.0×
FY 2016 5y median 5.9× FY 2025
P/B 5.8×
FY 2016 5y median 4.4× FY 2025
P/FCF 38.6×
FY 2016 5y median 49.3× FY 2025
EV/EBITDA 29.7×
FY 2016 5y median 27.2× FY 2025
EV/Sales 7.5×
FY 2016 5y median 6.5× FY 2025
FCF Yield 2.6%
FY 2016 5y median 2.0% FY 2025
Profitability
Gross Margin 69.0%
FY 2016 5y median 62.0% FY 2025
Operating Margin 19.8%
FY 2016 5y median 15.7% FY 2025
Net Margin 14.4%
FY 2016 5y median 11.1% FY 2025
ROE 11.9%
FY 2016 5y median 8.3% FY 2025
ROIC 8.8%
FY 2016 5y median 6.1% FY 2025
ROA 6.6%
FY 2016 5y median 4.5% FY 2025
Growth (YoY)
Revenue 19.9%
FY 2016 FY 2025
Operating Income 50.7%
FY 2016 FY 2025
EPS (diluted) 55.2%
FY 2016 FY 2025
Free Cash Flow 38.3%
FY 2016 FY 2025
Financial Health
Current Ratio 1.6×
FY 2016 5y median 1.5× FY 2025
Quick Ratio 1.1×
FY 2016 5y median 1.0× FY 2025
Debt / Equity 0.5×
FY 2016 5y median 0.5× FY 2025
Net Debt / EBITDA 2.0×
FY 2016 5y median 2.7× FY 2025
Interest Coverage 11.4×
FY 2016 5y median 6.8× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 1.8% FY 2025
Annual · latest fiscal year ends 2025-12-31